Generate Biomedicines, Inc. (GENB) vs Taysha Gene Therapies, Inc. (TSHA)

Generate Biomedicines, Inc. and Taysha Gene Therapies, Inc. are both Biotechnology companies. Generate Biomedicines, Inc. and Taysha Gene Therapies, Inc. are of similar size ($1.3B and $1.3B). Taysha Gene Therapies, Inc. has the higher net margin (0.00% vs −1,381.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Taysha Gene Therapies, Inc. leads on 8 and Generate Biomedicines, Inc. on 6.

Valuation

Metric GENB TSHA Biotechnology median
P/E n/m n/m 10.01
P/S 59.96 138.07 9.02
P/B 3.31 4.56 2.13
Price to free cash flow n/m n/m 24.99
EV/EBITDA n/m n/m 0.64
EV/Sales 41.05 106.23 9.01
Earnings yield (42.17%) (10.63%) (34.01%)
Free cash flow yield (20.00%) (8.88%) (24.62%)

Profitability

Metric GENB TSHA Biotechnology median
Gross margin 100.00% 100.00% 70.18%
Operating margin (1,382.04%) 0.00% 0.00%
Net margin (1,381.76%) 0.00% 0.00%
Free cash flow margin (1,199.36%) 0.00% 0.00%
Return on equity 1,091.11% (54.18%) (50.72%)
Return on assets (56.30%) (41.52%) (45.56%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GENB TSHA Biotechnology median
Revenue growth (TTM) — 18.96% 7.42%
EPS growth (last fiscal year) (13.66%) 5.56% 29.36%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric GENB TSHA Biotechnology median
Debt to equity 0.02 0.13 0.00
Current ratio 5.01 18.56 4.72
Net debt to EBITDA 0.97 2.47 1.01

Dividend

Metric GENB TSHA Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric GENB TSHA Biotechnology median
Market cap 1.27b 1.30b 157.22m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack